GCG and dilated cardiomyopathy: GLP-1 has been shown to increase glucose uptake in the myocardium (Nikolaidis et al., 2005a; Zhao et al., 2006) and to improve LV function in dogs with dilated cardiomyopathy (Nikolaidis et al., 2005a), in which GLP-1 also attenuated reperfusion-related mechanical ventricular dysfunction not associated with irreversible myocardial damage (“myocardial stunning”) (Nikolaidis et al., 2005b).